Cargando…
Update on the safety and efficacy of commercial ultrasound contrast agents in cardiac applications
Ultrasound contrast agents (UCAs) are currently used throughout the world in both clinical and research settings. The concept of contrast-enhanced ultrasound imaging originated in the late 1960s, and the first commercially available agents were initially developed in the 1980s. Today's microbub...
Autores principales: | Appis, Andrew W, Tracy, Melissa J, Feinstein, Steven B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676450/ https://www.ncbi.nlm.nih.gov/pubmed/26693339 http://dx.doi.org/10.1530/ERP-15-0018 |
Ejemplares similares
-
CEUS cardiac exam protocols International Contrast Ultrasound Society (ICUS) recommendations
por: Porter, Thomas R., et al.
Publicado: (2022) -
Safety Profile of Musculoskeletal Contrast-Enhanced Ultrasound with Sulfur Hexafluoride Contrast Agent
por: Fischer, Christian, et al.
Publicado: (2020) -
Towards MRI-guided cardiac ablation procedures with no contrast agent: safety and efficacy considerations
por: Guttman, Michael, et al.
Publicado: (2016) -
Ultrasound contrast agents
por: Ignee, Andre, et al.
Publicado: (2016) -
Effects of ultrasound and ultrasound contrast agent on vascular tissue
por: Wood, Steven C, et al.
Publicado: (2012)